Inventor · disambiguated record
Michalis Nicolaou
Also filed as: NICOLAOU MICHALIS
5 granted patents·6 pending applications·49 citations·filing 2007–2024
79Inventor score
Files withNICOLAOU MICHALIS5LORIA EMILE2NIPD GENETICS PUBLIC COMPANY LTD2AMYLIN PHARMACEUTICALS LLC1MIRATI THERAPEUTICS INC1
Top patents by PatentIndex Score
11 records- 0188US8603761B2GLP-1 receptor agonist bioassayAMYLIN PHARMACEUTICALS LLC·Filed 2012·Granted Dec 10, 2013·14 cites·20 claims
- 0285US8329419B2GLP-1 receptor agonist bioassaysNICOLAOU MICHALIS·Filed 2009·Granted Dec 11, 2012·17 cites·20 claims
- 0384US8207188B2Treatment of diseases modulated by a H4 receptor agonistNICOLAOU MICHALIS·Filed 2009·Granted Jun 26, 2012·11 cites·2 claims
- 0481US8207292B2Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugsNICOLAOU MICHALIS·Filed 2008·Granted Jun 26, 2012·7 cites·5 claims
- 0566US2025120981A1Mrtx1133 pharmaceutical compositionsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0666US2024200138A1Target-Enriched Multiplexed Parallel Analysis For Assessment Of Risk For Genetic ConditionsNIPD GENETICS PUBLIC COMPANY LTD·Filed 2023·Application pending·0 cites
- 0752US11879157B2Target-enriched multiplexed parallel analysis for assessment of risk for genetic conditionsNIPD GENETICS PUBLIC COMPANY LTD·Filed 2018·Granted Jan 23, 2024·0 cites·18 claims
- 0850US2007238750A1Pure isomers of tritoqualineNICOLAOU MICHALIS·Filed 2007·Application pending·0 cites
- 0942US2012101120A1Pure isomers of tritoqualineNICOLAOU MICHALIS·Filed 2011·Application pending·0 cites
- 1039US2012295933A1Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibators, lra drugs, anti-h1 and/or anti-h2 drugsLORIA EMILE·Filed 2012·Application pending·0 cites
- 1139US2013059878A1Treatment of diseases modulated by a h4 receptor agonistLORIA EMILE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →